Skip to main content
The George Institute for Global HealthThe George Institute for Global Health
Covid-19 Covid 19 Covid 19
Donate

Social links Global

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
The George Institute for Global Health
  • About us
    • Our Mission And Values
    • Our Strategy
    • Our History
    • How Our Research Is Different
    • Our People
    • Board Of Directors
    • Global Advisory Committee (ACRIS)
    • Our Affiliates And Collaborators
    • George Health
    • Annual Reports
    • Financial Statements
    • Environmental Sustainability Commitment
  • Our Work
    • Our Priorities
    • Better Treatments
    • Better Care
    • Healthier Societies
    • Ongoing Projects
    • Archived Projects
    • Publications
  • News & Events
    • Media Releases
    • News Stories
    • Media Coverage
    • Media Enquiries
    • Events
    • Past Events
    • Blogs / Profile Stories
    • E-Newsletters
    • Videos
    • Podcasts
  • Our Impact
    • Advocacy And Thought Leadership
    • Disruptive Social Entrepreneurship
    • Policy statements and recommendations
    • Case Studies And Examples
    • 20 Years Of Impact
    • Careers & studies
      • The George Experience
      • Current Job Opportunities
    • Contact Us
    • Get involved
      • Giving Opportunities
      • Building Back Better After COVID-19: The Research Agenda
      • Reclaiming Comprehensive Public Health: A Call to Action
      • Join Us Register
      • Clinical Trials

      Donate

    • Donate
    1. Home
    2. Publications

    POS-254 CLINICAL AND SAFETY OUTCOMES WITH APIXABAN VERSUS WARFARIN BY EGFR IN ADULTS WITH ATRIAL FIBRILLATION

    Authors
    M Jun
    Type of Publication
    Journal Article
    Year of Publication
    2022
    Journal
    Kidney International Reports
    Language
    Eng
    Volume
    7
    Number of Pages
    S111 - S112
    Links to full text
    • Google Scholar
    • BibTeX
    • EndNote X3 XML
    • EndNote 7 XML
    • Endnote tagged
    • Marc
    • RIS
    Search Publications

    Latest Publications

    • E-cigarettes: A continuing public health challenge in India despite comprehensive bans

      Preventive Medicine Reports

      2023

    • WCN23-0200 PREVALENCE AND TREATMENT PATTERNS OF ANAEMIA IN INDIVIDUALS WITH CHRONIC KIDNEY DISEASE ACROSS ASIA

      Kidney International Reports

      2023

    • WCN23-0069 EFFICACY AND SAFETY OF REDUCED-DOSE ORAL METHYLPREDNISOLONE IN IGA NEPHROPATHY: THE TESTING TRIAL

      Kidney International Reports

      2023

    • Outcomes in intervention research on snakebite envenomation: a systematic review

      F1000Research

      2022

    View all
    • About us
    • Our Work
    • News & Events
    • Our Impact
    • Careers & studies
    • Get involved
    • Thought leadership
    • Contact us
    • Donate

    The George Institute for Global Health

    Level 5, 1 King Street
    Newtown NSW 2042 Australia
    Tel: +61 2 8052 4300
    Fax: +61 2 8052 4301
    info@georgeinstitute.org

    The George Institute country sites:

    • The George Institute country sites:
    • Australia
    • China
    • India
    • UK
    • Affiliated with UNSW Sydney
    • In partnership with Imperial College London
    • In partnership with Manipal Academy of Higher Education

    Social links Global

    • Facebook
    • LinkedIn
    • Twitter
    • YouTube

    Subscribe to our E-newsletter

    Acknowledgement of Country

    The George Institute acknowledges the Gadigal People of the Eora Nation as the Traditional Custodians of the land on which our Australia office and Global Headquarters are built. We pay our respect to Elders past, present and emerging.

    Copyright © 2023 The George Institute

    Footer Links

    • Disclaimer
    • Privacy policy
    • Data sharing policy
    • Whistleblower policy
    • Modern slavery statement
    • Research code policy
    • PHS awards financial COI policy
    • Sitemap
    Please register to download the report
    ×

    Thank you for your interest in the FoodSwitch – State of the Food Supply Report 2022

    You should receive an email with a link to download the report.

    If you don't see it in your inbox, please check you spam folder in case it has been held there.

    Please enter a valid email address
    @Sarika - we need a title here
    ×